These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 27668766)
1. Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor. Choi YB; Yi ES; Lee JW; Sung KW; Koo HH; Yoo KH Bone Marrow Transplant; 2017 Jan; 52(1):47-52. PubMed ID: 27668766 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor. Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223 [TBL] [Abstract][Full Text] [Related]
3. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant. Dufour C; Pillon M; Sociè G; Rovò A; Carraro E; Bacigalupo A; Oneto R; Passweg J; Risitano A; Tichelli A; Peffault de Latour R; Schrezenmeier H; Hocshmann B; Peters C; Kulasekararaj A; Van Biezen A; Samarasinghe S; Hussein AA; Ayas M; Aljurf M; Marsh J Br J Haematol; 2015 May; 169(4):565-73. PubMed ID: 25683884 [TBL] [Abstract][Full Text] [Related]
4. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT. Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288 [TBL] [Abstract][Full Text] [Related]
5. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study. Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H Front Immunol; 2024; 15():1384640. PubMed ID: 38720904 [TBL] [Abstract][Full Text] [Related]
6. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia]. Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046 [No Abstract] [Full Text] [Related]
7. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia. Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S Front Immunol; 2022; 13():837335. PubMed ID: 35178053 [TBL] [Abstract][Full Text] [Related]
8. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation. Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354 [TBL] [Abstract][Full Text] [Related]
9. The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia. Marsh JCW; Risitano AM; Mufti GJ Biol Blood Marrow Transplant; 2019 Sep; 25(9):e277-e284. PubMed ID: 31129354 [TBL] [Abstract][Full Text] [Related]
10. Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation? Huang LF; Li L; Jia JS; Yang Y; Lin SY; Meng FK; Zhang DH; He GS Transplant Cell Ther; 2022 Sep; 28(9):586.e1-586.e7. PubMed ID: 35609866 [TBL] [Abstract][Full Text] [Related]
11. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis. Geng C; Liu X; Chen M; Yang C; Han B Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865 [TBL] [Abstract][Full Text] [Related]
12. Aplastic anemia: therapeutic updates in immunosuppression and transplantation. Scheinberg P Hematology Am Soc Hematol Educ Program; 2012; 2012():292-300. PubMed ID: 23233595 [TBL] [Abstract][Full Text] [Related]
13. First-line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy. Cheng Y; Xu Z; Zhang Y; Wu J; Wang F; Mo X; Chen Y; Han W; Jia J; Wang Y; Zhang X; Huang X; Zhang L; Xu L Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29297952 [TBL] [Abstract][Full Text] [Related]
14. Comparison of hematopoietic stem cell transplantation and repeated intensified immunosuppressive therapy as second-line treatment for relapsed/refractory severe aplastic anemia. Zhang L; Li J; Liang W; Zhang X; Chen S; Shi Y; Hao M; Zhao X; Gong M; Wei J; He Y; Jiang E; Han M; Zhang F; Feng S Front Immunol; 2024; 15():1425076. PubMed ID: 39221245 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of Frontline Haploidentical Hematopoietic Stem Cell Transplantation and Salvage Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia]. Xiao F; Liu Q; Fan D; Guo HX; Yan XQ; Zhao H; Liu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1683-1688. PubMed ID: 33067974 [TBL] [Abstract][Full Text] [Related]
16. Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia. Maury S; Balère-Appert ML; Pollichieni S; Oneto R; Yakoub-Agha I; Locatelli F; Dalle JH; Lanino E; Fischer A; Pession A; Huynh A; Barberi W; Mohty M; Risitano A; Milpied N; Socié G; Bacigalupo A; Marsh J; Passweg JR; Am J Hematol; 2013 Oct; 88(10):868-73. PubMed ID: 23804195 [TBL] [Abstract][Full Text] [Related]
17. The role of donor type and pre-transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia. Kashif R; Horn B; Milner J; Joyce M; Dalal M; Lee JJ; McNerney K; Cline J; Fort J; Castillo P; Galvez J; Alperstein W; Ligon J; Ziga E; Crawford D; Chellapandian D Pediatr Transplant; 2024 Jun; 28(4):e14784. PubMed ID: 38766976 [TBL] [Abstract][Full Text] [Related]
18. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia. Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350 [TBL] [Abstract][Full Text] [Related]
19. First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study. Liu L; Han B; Zhang Y; Lei M; Liu R; Lin Z; Jiao W; Zhang F; Fu R; Zhao X; Miao M; Zhang L; Wu D Bone Marrow Transplant; 2024 Oct; 59(10):1449-1457. PubMed ID: 39090437 [TBL] [Abstract][Full Text] [Related]
20. Single-Center Experience: immunosuppressive therapy as frontline treatment for 33 children with acquired severe aplastic anemia. Huang IA; Jaing TH; Yang CP; Hung IJ; Tsay PK; Luo CC; Sun CF Pediatr Hematol Oncol; 2009; 26(7):487-95. PubMed ID: 19863204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]